Jia Xiang
Director of Finance/CFO en HaploX Investment Holding Ltd. .
Perfil
Jia Xiang currently works at HaploX Investment Holding Ltd., as Chief Financial Officer & Board Secretary.
Mr. Xiang also formerly worked at Hydroelectric Corp., as M & A Director from 2015 to 2016.
Mr. Xiang received his graduate degree in 2020 from Shanghai Jiao Tong University.
Cargos activos de Jia Xiang
| Empresas | Cargo | Inicio |
|---|---|---|
HaploX Investment Holding Ltd.
 HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Director of Finance/CFO | - |
Antiguos cargos conocidos de Jia Xiang.
| Empresas | Cargo | Fin |
|---|---|---|
| Hydroelectric Corp. | Corporate Officer/Principal | 01/01/2016 |
Formación de Jia Xiang.
| Shanghai Jiao Tong University | Graduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
| Hydroelectric Corp. | |
HaploX Investment Holding Ltd.
HaploX Investment Holding Ltd. Miscellaneous Commercial ServicesCommercial Services HaploX Investment Holding Ltd. engages in the provision of genetic testing solutions with a focus on using molecular diagnostics technologies. It offers genetic testing results that enable full cycle health management for cancer and other patients as well as health screening and risk assessment for individuals, genetic testing of pathogenic microbes, and other pathogens, to research and development genetic testing primarily for biopharmaceutical companies and research institutes. The company was founded by Ming Yan Xu, Yuan Wen, Shi Fu Chen, and Wen Fang on November 29, 2021 and is headquartered in Hong Kong. | Commercial Services |
- Bolsa de valores
- Insiders
- Jia Xiang
